Industry
Three-year collaboration to pioneer new insights in microbial sciences and health applications.
New microbiome based therapy demonstrates safety and potential benefits for liver cirrhosis and mental health.
October 2024 saw notable activity in mergers, acquisitions, and strategic investments within the biotech and life sciences industries.
In the session's conclusion, CCNFSDU agreed to maintain the status quo for the next three to five years rather than start to work on new guidelines.
A symphony of microbiome insights: from early infancy to advanced age, the microbiome orchestrates critical processes that affect our health.
Industry
Sponsored by
The recently patented probiotic combination specifically focused on women’s urogenital health.
The partnership aims to accelerate the development and approval of microbiome-based therapeutics by harmonizing regulatory frameworks.
An analysis conducted by MicrobiomePost reveals an encouraging trend toward gender parity among speakers at major microbiome-focused conferences globally.
Harnessing microbiome-based biomarkers: a multidisciplinary Delphi Consensus and EU’s new initiative
Delphi survey highlights promises and challenges in clinical use of microbiome-based biomarkers.
Metabolon and the Scottish Early Rheumatoid Arthritis (SERA) Study announce partnership to better understand the molecular mechanisms of rheumatoid arthritis.
